Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
We offer this service in partnership with Treatlocal
References : Lieberman (2005)
The advantage of this drug is that it does not target the isoform B of the IR which is involved in glucose metabolism and therefore does not induce the hyperglycaemia and metabolic toxicity observed with IGF-1R targeted therapies or TKIs ( In vitro and patient-derived xenograft (PDX) models of prostate cancer have since found evidence that PTEN and the abnormally spliced ligand independent androgen receptor variant 7 (AR-V7) could have potential use as biomarkers for response to this combination of therapy
Common adverse effects: Injection site reactions: Pain, redness, swelling, or bruising at the injection site are frequently reported
US$ 25.33
US$ 27.81
US$ 21.60
